Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design - ScienceDirect
NASH: CRN Organization
National Institutes of Health (NIH) Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Nonalcoholic Fatty Liver D
Liver Pathology: Steatohepatitis | Liver Fellow Network
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management - ScienceDirect
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis - ScienceDirect
PDF) Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease | Naga Raj - Academia.edu
Liver Pathology: Steatohepatitis | Liver Fellow Network
NASH CRN NAFLD activity scoring system | Download Table
Common endpoints of clinical trials in NAFLD/NASH | Download Table
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
Non-Alcoholic Steatohepatitis (NASH) information for healthcare providers | Labcorp
Table 1 from Pathology of Non-Alcoholic Fatty Liver Disease | Semantic Scholar
Deep learning enables pathologist-like scoring of NASH models | Scientific Reports
Liver Pathology: Steatohepatitis | Liver Fellow Network
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science
Table 1 from Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. | Semantic Scholar
Management of non-alcoholic fatty liver disease | The BMJ
English | World Gastroenterology Organisation
Table 1 from Nonalcoholic fatty liver disease: Synopsis of current developments. | Semantic Scholar
EPOS™
Non-Alcoholic Steatohepatitis - A Review of the Landscape | DDDT
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup - Puri - 2012 - Clinical Liver Disease - Wiley Online Library
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials - ScienceDirect
